SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

FORM 6-K

 

Report of Foreign Issuer


Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934

 

For the month of November 2012

 

Commission File Number 000-20181

 

Sapiens International Corporation N.V.
(translation of registrant’s name into English)

 

c/o Landhuis Joonchi

Kaya Richard J. Beaujon z/n
P.O. Box 837

Willemstad,
Curaçao
(599) (9) 7366277
(address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F

Form 20-F        X           Form 40-F  ___

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

 

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange Act of 1934

Yes ___      No       X    

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-_______________.

 

 

 
 

 

  

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

  Sapiens International Corporation N.V.
   
   
   
Date: November 12, 2012 By:  /s/ Roni Giladi 
    Roni Giladi
Chief Financial Officer

 

 
 

 

Sapiens Q3 2012 Revenue Increases 67% to $29.6 Million

 

Q3 Operating profit grows 144% to $3.3 Million

Q3 Non-GAAP Operating Profit margin expands during 2012 to 14%

 

REHOVOT, Israel, November 13, 2012 - Sapiens International Corporation N.V. (NASDAQ and TASE: SPNS), a provider of innovative insurance software solutions and a member of the Formula Group (NASDAQ: FORTY and TASE: FORT), announces its financial results for the third quarter ended September 30, 2012.

 

Third Quarter Year-over-Year Financial and Business Highlights include:

 

·Revenue increased 67% to $29.6 million, compared to revenue of $17.8 million in the third quarter of 2011

·Non-GAAP operating profit increased 96% to $4.1 million, compared to $2.1 million in third quarter of 2011. Operating profit grows 144% to $3.3 million, compared to $1.4 million in the third quarter of 2011

·Non-GAAP net income increased 86% to $4.3 million, compared to $2.3 million in the third quarter of 2011. Net income increased by 123% to $3.5 million, compared to $1.6 million in the third quarter of 2011
·Non-GAAP operating profit margin expanded to 14.0%, compared to $11.9% for third quarter of 2011

·Non-GAAP diluted EPS was $0.10, compared to $0.07 per diluted share for the third quarter of 2011.

·Sapiens has signed several new customers, including MTL Insurance (US) with Sapiens ALIS and MDIS (UK) with Sapiens IDIT

·Cash position at the end of the quarter reached $33.1 million, compared to $21.5 million at December 31, 2011

 

Nine months Year-over-Year Financial Highlights include:

 

·Revenue increased 82% to $82.7 million, compared to revenue of $45.3 million in the same period last year
·Non-GAAP operating profit increased 80% to $11.2 million, compared to $6.2 million in same period last year
·Non-GAAP net income increased 76% to $11.0 million, compared to $6.2 million in the same period last year
·Non-GAAP diluted EPS was $0.26, compared to $0.24 per diluted share for the same period last year.

 

 
 

 

Roni Al Dor, President & CEO of Sapiens International, commented, “Q3 was a strong quarter for Sapiens. We were extremely pleased with the opportunity to partner with new customers, further establishing Sapiens as a market leader. Sapiens client base is rapidly growing, and our market recognition in the global market is further enhanced, with the adoption of our Property & Casualty, Life & Annuity and Decision Management solutions. We are growing rapidly, profitably and we are expanding margins. To meet our growth plans, we are also growing our team of insurance and technology experts, globally. Sapiens continues to execute and is well positioned to accelerate profitable growth as a leading global provider of innovative software solutions and services.”

 

Increased 2012 Guidance

 

Mr. Al Dor continued, “As a result of the year-to-date progress, and our strengthening sales pipeline, we are increasing our 2012 revenue guidance. We now expect to exceed $113 million in revenue for the year.”

 

 
 

 

Non-GAAP Financial Measures

 

Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: amortization of acquired intangible assets, share-based compensation expenses and certain business combination accounting entries. The purpose of such adjustments is to give an indication of our performance exclusive of non-cash charges and other items that are considered by management to be outside of our core operating results. Our non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. We believe that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with our results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate our results of operations in conjunction with the corresponding GAAP measures. Our management regularly uses our supplemental non-GAAP financial measures internally to understand, manage and evaluate our business and make operating decisions. These non-GAAP measures are among the primary factors management uses in planning for and forecasting future periods.

 

 

 

U.S. Dollars in thousands, except per share amounts        
                 
   For the three months ended   For the nine months ended 
U.S GAAP basis  30/09/2012   30/09/2011   30/09/2012   30/09/2011 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
Revenues   29,574    17,757    87,739    45,341 
Gross profit   12,919    7,749    35,355    20,603 
Operating profit   3,323    1,362    8,526    4,761 
Net income   3,474    1,555    8,464    4,853 
Basic earnings per share   0.09    0.05    0.21    0.20 
Diluted earnings per share   0.08    0.05    0.20    0.18 
                     
Non-GAAP                    
Revenues   29,549    17,834    83,058    45,418 
Gross profit   13,956    8,916    38,871    24,135 
Operating profit   4,145    2,117    11,168    6,200 
Net income   4,254    2,290    10,978    6,227 
Basic earnings per share   0.11    0.08    0.28    0.25 
Diluted earnings per share   0.10    0.07    0.26    0.24 

 

About Sapiens International

 

Sapiens International Corporation (NASDAQ and TASE: SPNS) is a global provider of innovative software solutions for the financial services market with focus on insurance. We serve over 100 financial services customers, backed by a team of over 800 experts, operating through fully-owned subsidiaries in North America, the United Kingdom, EMEA and Asia Pacific.

 

 
 

 

Except for historical information contained herein, the matters set forth in this release are forward-looking statements that are dependent on certain risks and uncertainties, including such factors, among others, as market acceptance, market demand, pricing, changing regulatory environment, changing economic conditions, risks in new product and service development, the effect of accounting policies, specific system configurations and software needs of individual customers and other risk factors.

 

Investor Relations Contact: 
Roni Giladi, CFO 
Sapiens International 
Tel: +972-8-9382721 
E-mail: roni.g@sapiens.com

 

Or

 

James Carbonara, Regional Vice President

Hayden IR

Office: (646)-755-7412

E-mail: James@haydenir.com

 

 
 

 

SAPIENS INTERNATIONAL CORPORATION N.V.

Condensed Consolidated Statements of Operations

(U.S. Dollars in thousands, except per share amounts)

 

   For the three months ended   For the nine months ended 
   9/30/2012   9/30/2011   9/30/2012   9/30/2011 
                 
   Unaudited   Unaudited   Unaudited   Unaudited 
                 
Revenues  $29,574   $17,757   $82,739   $45,341 
                     
Cost of revenues  $16,655   $10,008   $47,384   $24,738 
                     
Gross Profit   12,919    7,749    35,355    20,603 
                     
Operating expenses                    
Research and development, net  $2,830   $1,655   $7,575   $3,906 
Selling, marketing, general and administrative  $6,766   $4,732   $19,254   $11,936 
Total operating expenses  $9,596  $6,387   $26,829  $15,842 
                     
Operating Income   3,323    1,362   $8,526    4,761 
                     
Financial income, net  $(239)  $(276)  $(385)  $(175)
Taxes and other expenses (income), net  $43   $41   $424   $41 
                     
Net Income  $3,519   $1,597   $8,487   $4,895 
                     
Attributetable to non-controlling interest  $45   $42   $23   $42 
                     
Net income attributable to Sapiens shareholders  $3,474   $1,555   $8,464   $4,853 
                     
Earnings per share                    
Basic  $0.09   $0.05   $0.21   $0.20 
Diluted  $0.08   $0.05   $0.20   $0.18 
                     
Weighted average number of shares used to computation of earnings per share                    
                
Basic   40,294    29,894    39,771    24,681 
Diluted   42,230    31,916    41,733    26,445 

 

 
 

 

SAPIENS INTERNATIONAL CORPORATION N.V.

Reconciliation  of GAAP to Non-GAAP results

(U.S. Dollars in thousands, except per share amounts)

 

   For the three months ended   For the year ended 
   9/30/2012   9/30/2011   9/30/2012   9/30/2011 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
                 
GAAP revenues   29,574    17,757    82,739    45,341 
Valuation adjustment on acquired deferred revenue and long term contract   (25)   77    319    77 
Non-GAAP revenues   29,549    17,834    83,058    45,418 
                     
GAAP gross profit   12,919    7,749    35,355    20,603 
Revenues adjustment   (25)   77    319    77 
Amortization of capitalized software   857    952    2,566    3,317 
Amortization of other intangible assets   205    138    631    138 
Non-GAAP gross profit   13,956    8,916    38,871    24,135 
                     
GAAP operating income   3,323    1,362    8,526    4,761 
Gross profit adjustment   1,037    1,167    3,516    3,532 
Capitalization of software development   (730)   (970)   (2,645)   (3,400)
Amortization of other intangible assets   357    486    1,305    1,076 
Stock-based compensation   158    72    466    231 
Non-GAAP operating profit   4,145    2,117    11,168    6,200 
                     
                     
GAAP net income attributable to Sapiens shareholders   3,474    1,555    8,464    4,853 
Operating income adjustments   822    755    2,642    1,439 
Non-controlling interest in amortization intangible assets   (20)        (66)     
Deferred taxes related to acquisition   (22)   (20)   (62)   (65)
Non-GAAP net income  attributable to Sapiens shareholders   4,254    2,290    10,978    6,227 
                     
Non-GAAP basic earnings per share   0.11    0.08    0.28    0.25 
                     
Non-GAAP diluted earnings  per share   0.10    0.07    0.26    0.24 
                     
Weighted average number of shares used to computation of earnings per share                    
Basic   40,294    29,894    39,771    24,681 
                     
Diluted   42,230    31,916    41,733    26,445 

 

 
 

 

SAPIENS INTERNATIONAL CORPORATION N.V.    

Condensed Consolidated Balance Sheets    

(U.S. Dollars in thousands)    

 

   9/30/2012   12/31/2011 
         
   (Unaudited)   (Audited) 
Assets          
           
Cash and cash equivalents  $33,110   $21,460 
Restricted cash   341    456 
Trade receivables, net   16,978    14,484 
Other receivables and prepaid expenses   3,097    3,229 
Total current assets   53,526    39,629 
           
           
Property and equipment, net   2,007    1,814 
Severance pay fund   9,793    10,172 
Other intangible assets, net   31,979    35,138 
Goodwill   65,427    66,715 
Total Long-term assets   109,206    113,839 
           
Total assets  $162,732   $153,468 
           
Liabilities and Equity          
           
Trade payables  $3,760   $2,559 
Accrued expenses and other liabilities   18,335    19,731 
Deferred revenue   10,417    9,603 
Total current liabilities   32,512    31,893 
           
Other long-term liabilities   631    614 
Accrued severance pay   11,369    10,714 
           
Total long-term liabilities   12,000    11,328 
           
EQUITY   118,220    110,247 
           
Total liabilities and shareholders' equity  $162,732   $153,468